Dishman Of India Rejects World Bank Financing For Planned Expansion
This article was originally published in PharmAsia News
Executive Summary
India's Dishman Pharmaceuticals says it has rejected World Bank conditions for new financing for the firm, opting instead to try other means to raise funds to support its expansion plans. Medical Director J.R. Vyas said his company did not like the World Bank conditions. Funds are needed to support Dishman's five-year expansion plan that include developing new products and building new facilities in India and China. The firm also plans to strengthen its subsidiaries and enter into various joint ventures. (Click here for more